摘要
背景:纵观人类文明史,癌症一直是一个重大的健康问题。尽管现代医学取得了进步,但癌症的彻底治疗或切除。细胞仍然是一项具有挑战性的任务。长春花碱,一种从长春花中提取的生物碱。唐是临床上使用的著名的抗肿瘤药物之一。改善双性恋这一结构复杂的分子具有潜在的和减少副作用的作用,一些相关的类似物已经被报道。本文回顾了最近报道的结构修饰的vinbl。阿司匹林类似物及其对生物活性的影响。 方法:对最近报道的长春碱类似物进行数据库检索。同时考虑了上(catharanthine)和下(vindoline)结构单元的作用,对抗癌活性的官能团修饰进行了讨论。此外,美国国家卫生研究院正在考虑以长春花碱为基础的不同类型癌症的制剂也被讨论。 结果:共收录文献50余篇,包括计算文献和实验文献。本文分析了长春碱的作用机理,并对其作用机理进行了探讨。e及其类似物。讨论了每种功能对其抗癌活性的重要性。这次审查确定了长春碱核心的潜在位置,在那里,修饰导致了提高了抗癌活性。此外,还讨论了几种不同阶段临床试验的新剂型。 结论:文中强调长春碱在肿瘤化疗中的重要性。文献调查证实,现在有可能合成具有活性的微粒体中的新分子范围。不仅是分子的外围,这个神奇分子的核心结构可以被修改,以实现下一代的抗肿瘤剂。
关键词: 生物碱,癌症,衍生物,临床试验,长春碱,抗肿瘤药。
Current Medicinal Chemistry
Title:Next Generation Antineoplastic Agents: A Review on Structurally Modified Vinblastine (VBL) Analogues
Volume: 25 Issue: 14
关键词: 生物碱,癌症,衍生物,临床试验,长春碱,抗肿瘤药。
摘要: Background: Throughout the history of human civilizations, cancer has been a major health problem. Despite the advancements made by modern medical sciences, complete treatment or removal of cancerous cells is still a challenging task. Vinblastine, an alkaloid obtained from Catharanthus roseus (L.) G. Don is one of the prominent antineoplastic agents that is being clinically used. To improve the biological potential and reduce sideeffects of this structurally complex molecule, several related analogues have been reported. The present article reviews recently reported structurally modified vinblastine analogues and its impact on biological activity.
Methods: We carried out a comprehensive database search on recently reported vinblastine analogues. Both upper (catharanthine) and lower (vindoline) structural units have been considered. The role of functional group modification on anticancer activities has been discussed. In addition, formulations based on vinblastine being considered by NIH, USA for different types of cancers have also been discussed.
Results: Around fifty papers were included in the review, including computational and experimental ones. These papers were analysed to discuss the mechanism of action of the parent vinblastine molecule and their analogues. The importance of each functionalities on its anticancer activity have been discussed. This reviewed identified the potential sites of vinblastine core where modification led to improved anticancer activity. Furthermore, several new formulations have also been discussed which are under different phases of clinical trial.
Conclusion: The present article highlights the importance of vinblastine in cancer chemotherapy. Literature survey confirms that it is now possible to synthesize new molecules with activity in picomolar range. Not only the periphery of the molecule, the core structure of this magical molecule can be modified to achieve next generation antineoplastic agents.
Export Options
About this article
Cite this article as:
Next Generation Antineoplastic Agents: A Review on Structurally Modified Vinblastine (VBL) Analogues, Current Medicinal Chemistry 2018; 25 (14) . https://dx.doi.org/10.2174/0929867324666170502123639
DOI https://dx.doi.org/10.2174/0929867324666170502123639 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Glioma: Tryptophan Catabolite and Melatoninergic Pathways Link microRNA, 14-3- 3, Chromosome 4q35, Epigenetic Processes and other Glioma Biochemical Changes
Current Pharmaceutical Design Pro-apoptotic Activity of BH3-only Proteins and BH3 Mimetics: from Theory to Potential Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry MicroRNAs in Cancer Stem Cells: New Regulators of Stemness
Current Pharmaceutical Design Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain
CNS & Neurological Disorders - Drug Targets A Role for the Inflammatory Mediators Cox-2 and Metalloproteinases in Cancer Stemness
Anti-Cancer Agents in Medicinal Chemistry Nanocarriers for the Simultaneous Co-Delivery of Therapeutic Genes and Anticancer Drugs
Current Pharmaceutical Biotechnology Geniposide Attenuates Oligomeric Aβ<sub>1-42</sub>-Induced Inflammatory Response by Targeting RAGE-Dependent Signaling in BV2 Cells
Current Alzheimer Research Recent Developments in the Formulation of Nanoliposomal Delivery Systems
Current Nanomaterials Mesenchymal Stem Cells: New Approaches for the Treatment of Neurological Diseases
Current Stem Cell Research & Therapy Bacteria and Bacterial Toxins as Therapeutic Agents for Solid Tumors
Current Cancer Drug Targets Expression and Function of Angiomodulating Cytokines in Rheumatoid Arthritis and Experimental Arthritis: Important Therapeutic Targets
Current Immunology Reviews (Discontinued) Imaging of Cyclooxygenase-2 (COX-2) Expression: Potential Use in Diagnosis and Drug Evaluation
Current Pharmaceutical Design Targeting Glioblastoma: The Current State of Different Therapeutic Approaches
Current Neuropharmacology Phosphorothioate Oligonucleotides: Effectiveness and Toxicity
Current Drug Targets Automated PET Radiotracer Manufacture on the BG75 System and Imaging Validation Studies of [18F]fluoromisonidazole ([18F]FMISO)
Current Radiopharmaceuticals EGFR High Expression, but not KRAS Status, Predicts Sensitivity of Pancreatic Cancer Cells to Nimotuzumab Treatment In Vivo
Current Cancer Drug Targets RNA Interference in Cancer: Targeting the Anti-Apoptotic Protein c-FLIP for Drug Discovery
Mini-Reviews in Medicinal Chemistry The NK-1 Receptor is Involved in the Antitumoural Action of L-733,060 and in the Mitogenic Action of Substance P on Human Pancreatic Cancer Cell Lines
Letters in Drug Design & Discovery Ex Vivo Proton NMR Analysis and Characterization of Thymus Lipid Metabolites and their Variation with Age in C57BL/6 Mice
Current Aging Science The Current State of Potential Therapeutic Modalities for Glioblastoma Multiforme: A Clinical Review
Current Drug Metabolism